129 related articles for article (PubMed ID: 6120738)
1. Healing of gastric ulcers after one, two, and three months of ranitidine.
Ashton MG; Holdsworth CD; Ryan FP; Moore M
Br Med J (Clin Res Ed); 1982 Feb; 284(6314):467-8. PubMed ID: 6120738
[TBL] [Abstract][Full Text] [Related]
2. A double-blind endoscopically controlled trial of ranitidine in a high incidence area.
Moshal MG; Spitaels JM; Khan F
Scand J Gastroenterol Suppl; 1981 Jun; 69():129-31. PubMed ID: 6119777
[TBL] [Abstract][Full Text] [Related]
3. Comparison of twice-daily ranitidine and placebo in the treatment of duodenal ulcer--a multicentre study in the United Kingdom.
Lee FI; Fielding JD; MacKay C; Mitchell K; Mohammed R; Holmes GK; Hine KR; Gibson JA; Lochee-Bayne E; Stone WD; Orchard RT; Calcraft BJ; Rose JA
Hepatogastroenterology; 1982 Jun; 29(3):127-9. PubMed ID: 6125463
[TBL] [Abstract][Full Text] [Related]
4. Ranitidine: a pilot study in Japan.
Takemoto T; Okazaki Y; Okita K; Namiki M; Ishikawa M; Oshiba S; Kurokawa K
Scand J Gastroenterol Suppl; 1981 Jun; 69():125-8. PubMed ID: 6119776
[TBL] [Abstract][Full Text] [Related]
5. Ranitidine and duodenal ulceration: a short-term and maintenance study.
Sheers R; McKay JS; Hughes S
J R Soc Med; 1982 May; 75(5):323-6. PubMed ID: 6122738
[TBL] [Abstract][Full Text] [Related]
6. Effect of ranitidine on healing of peptic ulcer: a 2-month study.
Leroux P; Farley A; Archambault A; Pilon G; Gosselin D; Paré P; Lévesque D; Sherbaniuk R; Thomson AB
Am J Gastroenterol; 1983 Apr; 78(4):227-30. PubMed ID: 6301262
[TBL] [Abstract][Full Text] [Related]
7. Treatment of duodenal ulcer with ranitidine, a new histamine H2-receptor antagonist.
Berstad A; Kett K; Aadland E; Carlsen E; Frislid K; Saxhaug K; Kruse-Jensen A
Scand J Gastroenterol; 1980; 15(5):637-9. PubMed ID: 6108607
[TBL] [Abstract][Full Text] [Related]
8. The treatment of "cimetidine resistant" peptic ulcers by ranitidine hydrochloride: a new histamine H2-receptor antagonist.
Mohammed R; Mitchell KG; Mackay C
Curr Med Res Opin; 1981; 7(8):523-5. PubMed ID: 6118237
[TBL] [Abstract][Full Text] [Related]
9. Multicentre double blind clinical trial on ranitidine for gastroduodenal ulcer.
Gibinski K; Nowak A; Gabryelewicz A; Szalaj W; Hasik J; Klincewicz H; Pokora J; Radwan P; Kosecki P; Pachlewski J
Hepatogastroenterology; 1981 Aug; 28(4):216-7. PubMed ID: 6115807
[TBL] [Abstract][Full Text] [Related]
10. Placebo controlled studies with ranitidine in duodenal ulcer.
Dobrilla G; Barbara L; Bianchi Porro G; Felder M; Mazzacca G; Miglioli L; Pera A; Petrillo M; Sabbatini F; Verme G
Scand J Gastroenterol Suppl; 1981 Jun; 69():101-7. PubMed ID: 6119771
[TBL] [Abstract][Full Text] [Related]
11. Nizatidine versus ranitidine in the treatment of peptic ulcer disease: report on the Dutch investigation as part of a European multicentre trial.
Kuipers EJ; Hazenberg HJ; Quik RF; Hazenberg BP; de Zwart PA
Neth J Med; 1990 Aug; 37(1-2):58-62. PubMed ID: 1977089
[TBL] [Abstract][Full Text] [Related]
12. Treatment of refractory peptic ulcer with omeprazole or continued H2 receptor antagonists: a controlled clinical trial.
Bardhan KD; Naesdal J; Bianchi Porro G; Petrillo M; Lazzaroni M; Hinchliffe RF; Thompson M; Morris P; Daly MJ; Carroll NJ
Gut; 1991 Apr; 32(4):435-8. PubMed ID: 1673953
[TBL] [Abstract][Full Text] [Related]
13. Ranitidine in uncomplicated duodenal ulceration. A double-blind endoscopically controlled trial.
Moshal MG; Spitaels JM; Khan F
S Afr Med J; 1981 Sep; 60(10):393-4. PubMed ID: 6269234
[TBL] [Abstract][Full Text] [Related]
14. [Therapy and prevention of duodenal and gastric ulcer with histamine-H2-receptor antagonists].
Hentschel E
Wien Med Wochenschr; 1983; 133(4-5):104-7. PubMed ID: 6134397
[No Abstract] [Full Text] [Related]
15. Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases.
Brogden RN; Carmine AA; Heel RC; Speight TM; Avery GS
Drugs; 1982 Oct; 24(4):267-303. PubMed ID: 6128216
[TBL] [Abstract][Full Text] [Related]
16. Double blind comparative study of omeprazole and ranitidine in patients with duodenal or gastric ulcer: a multicentre trial. Cooperative study group.
Gut; 1990 Jun; 31(6):653-6. PubMed ID: 2199347
[TBL] [Abstract][Full Text] [Related]
17. [The treatment with ranitidine of 40 gastroduodenal ulceration: evaluation of an open study (author's transl)].
Barbier P; Dumont A; Adler M
Acta Gastroenterol Belg; 1979; 42(7-8):268-74. PubMed ID: 44956
[No Abstract] [Full Text] [Related]
18. [Multi-center double-blind clinical trial of ranitidine in the treatment of stomach and duodenal ulcers].
Gibiński K; Nowak A; Gabrylewicz A; Laszewicz W; Hasik J; Klincewicz H; Pokora J; Czarnecki J; Kosecki J; Pachlewski J
Pol Arch Med Wewn; 1982; 68(3):117-24. PubMed ID: 6133269
[No Abstract] [Full Text] [Related]
19. [Newly developed H2-receptor antagonists in the treatment of peptic ulcer disease].
Simon B; Müller P; Dammann HG
Wien Med Wochenschr; 1982 May; 132(10):223-8. PubMed ID: 6126962
[TBL] [Abstract][Full Text] [Related]
20. Comparison of twice-daily ranitidine with standard cimetidine treatment of duodenal ulcer.
Walt RP; Trotman IF; Frost R; Golding PL; Shepherd TH; Rawlings J; Hunt RH; Colin-Jones D; Milton-Thompson GJ; Misiewicz JJ
Gut; 1981 Apr; 22(4):319-22. PubMed ID: 6113192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
